Eight‐year efficacy and safety of tenofovir alafenamide for treatment of chronic hepatitis B virus infection: Final results from two randomised phase 3 trials

Maria Buti, Young‐Suk Lim, Henry Lik Yuen Chan, Kosh Agarwal, Patrick Marcellin, Maurizia R. Brunetto, Wan‐Long Chuang, Harry L. A. Janssen, Scott K. Fung, Namiki Izumi, Maciej S. Jablkowski, Dzhamal Abdurakhmanov, Frida Abramov, Hongyuan Wang, Irina Botros, Leland J. Yee, Roberto Mateo, John F. Flaherty, Anu Osinusi, Calvin Q. Pan, X. Shalimar, Wai‐Kay Seto, Edward J. Gane

Open source

DOI: 10.1111/apt.18278
Published: 2024-09-27
Container: Alimentary Pharmacology & Therapeutics
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/apt.18278,
  title = {Eight‐year efficacy and safety of tenofovir alafenamide for treatment of chronic hepatitis B virus infection: Final results from two randomised phase 3 trials},
  author = {Maria Buti and Young‐Suk Lim and Henry Lik Yuen Chan and Kosh Agarwal and Patrick Marcellin and Maurizia R. Brunetto and Wan‐Long Chuang and Harry L. A. Janssen and Scott K. Fung and Namiki Izumi and Maciej S. Jablkowski and Dzhamal Abdurakhmanov and Frida Abramov and Hongyuan Wang and Irina Botros and Leland J. Yee and Roberto Mateo and John F. Flaherty and Anu Osinusi and Calvin Q. Pan and X. Shalimar and Wai‐Kay Seto and Edward J. Gane},
  year = {2024},
  journal = {Alimentary Pharmacology \&amp; Therapeutics},
  doi = {10.1111/apt.18278},
  url = {https://doi.org/10.1111/apt.18278}
}

RIS

TY  - JOUR
TI  - Eight‐year efficacy and safety of tenofovir alafenamide for treatment of chronic hepatitis B virus infection: Final results from two randomised phase 3 trials
AU  - Maria Buti
AU  - Young‐Suk Lim
AU  - Henry Lik Yuen Chan
AU  - Kosh Agarwal
AU  - Patrick Marcellin
AU  - Maurizia R. Brunetto
AU  - Wan‐Long Chuang
AU  - Harry L. A. Janssen
AU  - Scott K. Fung
AU  - Namiki Izumi
AU  - Maciej S. Jablkowski
AU  - Dzhamal Abdurakhmanov
AU  - Frida Abramov
AU  - Hongyuan Wang
AU  - Irina Botros
AU  - Leland J. Yee
AU  - Roberto Mateo
AU  - John F. Flaherty
AU  - Anu Osinusi
AU  - Calvin Q. Pan
AU  - X. Shalimar
AU  - Wai‐Kay Seto
AU  - Edward J. Gane
PY  - 2024
JO  - Alimentary Pharmacology &amp; Therapeutics
DO  - 10.1111/apt.18278
UR  - https://doi.org/10.1111/apt.18278
ER  -

APA

Buti, M., Lim, Y., Chan, H. L. Y., Agarwal, K., Marcellin, P., Brunetto, M. R., Chuang, W., Janssen, H. L. A., Fung, S. K., Izumi, N., Jablkowski, M. S., Abdurakhmanov, D., Abramov, F., Wang, H., Botros, I., Yee, L. J., Mateo, R., Flaherty, J. F., Osinusi, A., Pan, C. Q., Shalimar, X., Seto, W., & Gane, E. J. (2024). Eight‐year efficacy and safety of tenofovir alafenamide for treatment of chronic hepatitis B virus infection: Final results from two randomised phase 3 trials. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.18278

Source records

crossref · retrieved 2026-09-26T23:28:48.053Z